Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded 'Acute lymphoid leukemia' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource in the Resources section.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a maintenance/version bump with no visible changes to study details.SummaryDifference0.1%

- Check34 days agoChange DetectedUpdated site revision from v3.4.2 to v3.4.3; the previous revision tag has been removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (v3.4.1) on the page, which are site-wide versioning updates rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check77 days agoChange DetectedAdded a Show glossary option and updated footer metadata to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.